Shaperon
Business Services · South Korea · 11-50 Employees
View Company Info for Free
Overview
Headquarters
174-10 Jagok-ro Gangnam-gu Ste 218 / 608...Website
www.shaperon.comRevenue
<$5 MillionIndustry
About Shaperon
Shaperon is a clinical-stage biotech company developing novel inflammasome inhibitors in the Republic of Korea. Its unique mechanism of action via GPCR19-P2X7 modulation suppresses a broad spectrum of inflammatory cytokines by controlling both priming and activation phase of inflammasome. Shaperon is engaged in multiple clinical programs in atopic dermatitis, COVID-19, Alzheimer's disease, idiopathic pulmonary fibrosis (IPF), ulcerative colitis, and NASH. Additionally, Shaperon is developing multi-valent and multi-specific nanobodies in oncology and viral infections.Explore more
Shaperon Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Shaperon Tech Stack
A closer look at the technologies used by Shaperon
See more technologies
Top Business Services Companies
Frequently Asked Questions Regarding Shaperon
Sign Up For FreeTo access detailed company insights
Shaperon is a clinical-stage biotech company developing novel inflammasome inhibitors in the Republic of Korea. Its unique mechanism of action via GPCR19-P2X7 modulation suppresses a broad spectrum of inflammatory cytokines by controlling both priming and activation phase of inflammasome. Shaperon is engaged in multiple clinical programs in atopic... Read More
